Microdelics™ The Enhancement of Normal Functionality
Disclaimer: Our products are strictly sold for research purposes only, and are not recommended for human consumption or veterinarian use. Any references, videos or pictures related to microdosing these substances for human consumption are for education and safety purposes only.
Microdelics™ – The Enhancement of Normal Functionality
The Latest Psychedelic News & Articles
Stay up to date with the latest publications, news content and studies on psychedelics.
Ketamine For Depression: A Mental Health Breakthrough
Depression can be an almost intolerable burden to live with. While antidepressants help many to soothe their symptoms, many others find no relief in these substances. A decades-old drug, ketamine, is now offering hope to many of these people. Ketamine was first discovered in 1962.
-
Psychedelics As Therapeutic Treatments Focus Of New UW-Madison Psychedelics Master’s Degree GalleryPsychedelics As Therapeutic Treatments Focus Of New UW-Madison Psychedelics Master’s Degree
5-MEO-DMT, Articles & News, Ayahuasca, Cannabis, DMT, Dosing Articles, Education, Iboga, Ibogaine, Ketamine, LSD, Magic Mushrooms, MDMA, Mescaline, Microdosing, Psychedelic Therapy, Psychedelics & Death, Sex & Psychedelics
Psychedelics As Therapeutic Treatments Focus Of New UW-Madison Psychedelics Master’s Degree
"We're particularly interested in training students to enter the growth pharmaceutical industry surrounding the use of these substances, providing them with the tools to understand the data and also to work in an ethical manner and adhere to all the regulatory pieces surrounding the use of these compounds," he said.
Compass Pathways (CMPS) Potential Lead in Psychedelic Sector
A couple of companies in the Magic Mushroom sector that are worth talking about are Compass Pathways (CMPS) and Minerco, Inc. (MINE). CMPS is ahead in the race is already working on a formulation of psilocybin to help with treatment-resistant depression.